How do we cre­ate the ef­fect­ive, safe and sustainable drug treat­ments of the fu­ture?

The Master’s Programme in Pharmaceutical Research, Development and Safety offers the opportunity to obtain a comprehensive overview of the life cycle of drugs and their use. The study program combines compulsory and optional courses with study tracks that focus on three possible subdisciplines: 1) drug discovery and pharmacology, 2) drug development and 3) medication safety and effectiveness. The programme combines research-oriented studies and high-quality pedagogical methods and integrates the perspective of Green and Sustainable Pharmacy into the curriculum, essential for managing the global sustainability challenge.

Upon graduating, you earn a degree in pharmaceutical sciences and gain expertise relevant to a wide range of careers in R&D and healthcare regulatory and management tasks in academia, pharmaceutical industry or the public sector (e.g. regulatory agencies). The programme is hosted by the Faculty of Pharmacy, University of Helsinki, an internationally recognised drug research institute.

Why phar­ma­ceut­ical research, de­vel­op­ment and safety?

The ageing population and the need for rapidly evolving medication solutions are factors that highlight the growing role and need of experts in pharmaceuticals, their use and regulatory processes in society.

In the Master’s Programme in Pharmaceutical Research, Development and Safety, you will:

• acquire a comprehensive overview of the life cycle of drugs and their use.
• obtain a unique perspective of Green and Sustainable Pharmacy as well as essential knowledge for managing the global sustainability challenge.
• be trained for research and development (R&D) oriented positions and as professionals for healthcare regulatory, management, policy-making and pharmaceutical industry positions.
• earn a Master of Science degree from a programme hosted by the Faculty of Pharmacy, a top-level drug research institute, with an extensive network of partners and considerable external research funding.

Please note that the degree earned in this programme does not qualify for legalized healthcare professional status in the EU area.